Lu Li
Stock Analyst at UBS
(2.34)
# 3,159
Out of 4,683 analysts
26
Total ratings
70%
Success rate
5.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Rated: Hold | $17 → $12 | $15.05 | -20.27% | 7 | May 7, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $375 | $414.44 | -9.52% | 2 | May 6, 2026 | |
| VCYT Veracyte | Maintained: Buy | $48 → $52 | $44.04 | +18.07% | 6 | May 6, 2026 | |
| DHR Danaher | Maintained: Buy | $250 | $215.97 | +15.76% | 1 | Apr 22, 2026 | |
| FLGT Fulgent Genetics | Maintained: Buy | $35 → $22 | $19.95 | +10.28% | 3 | Mar 2, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $8 → $6 | $3.19 | +88.09% | 7 | Feb 25, 2026 |
QuidelOrtho
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $15.05
Upside: -20.27%
Waters
May 6, 2026
Maintained: Hold
Price Target: $330 → $375
Current: $414.44
Upside: -9.52%
Veracyte
May 6, 2026
Maintained: Buy
Price Target: $48 → $52
Current: $44.04
Upside: +18.07%
Danaher
Apr 22, 2026
Maintained: Buy
Price Target: $250
Current: $215.97
Upside: +15.76%
Fulgent Genetics
Mar 2, 2026
Maintained: Buy
Price Target: $35 → $22
Current: $19.95
Upside: +10.28%
Myriad Genetics
Feb 25, 2026
Maintained: Hold
Price Target: $8 → $6
Current: $3.19
Upside: +88.09%